Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 319
Filter
Add more filters

Publication year range
1.
Sci Rep ; 14(1): 6871, 2024 03 22.
Article in English | MEDLINE | ID: mdl-38519552

ABSTRACT

Previous findings indicated that the laser photobiomodulation is more effective than the control or placebo in preserving the alveolar socket. This study aimed to compare two different lasers regarding their effectiveness in aiding alveolar socket preservation. Twenty extraction sockets were selected then divided into two equal groups. Group A was exposed to 650 nm Diode laser, and Group B to 810 nm Diode laser following the same protocol and parameters after a standard alveolar socket preservation procedure with collagen plug. Radiographic analysis with cone beam computed tomography was done to compare the alveolar bone surface area immediately after extraction and three months post-operatively, while bone samples collected before implant drilling were histologically examined for newly formed bone evaluation and histomorphometric analysis in terms of percentage of new bone surface area, percentage of unmineralized bone and finally, immunohistochemical analysis of Osteocalcin reaction surface area as well as optical density. Radiographically, infrared (810 nm) Diode effect on alveolar bone surface area has significantly exceeded the red laser, while histologically, red (650 nm) Diode has demonstrated statistical significance regarding all parameters; newly formed bone surface area percentage, unmineralized bone area percentage and finally Osteocalcin bone marker reaction surface area percentage and optical density. Under the specified conditions and laser parameters, photobiomodulation using the 810 nm Diode got the upper hand radiographically, yet histologically, the red 650 nm Diode managed to dominate all histological parameters when both employed as an adjunct to alveolar socket preservation procedures.


Subject(s)
Alveolar Bone Loss , Low-Level Light Therapy , Humans , Alveolar Process/diagnostic imaging , Alveolar Process/surgery , Alveolar Process/pathology , Tooth Socket/diagnostic imaging , Tooth Socket/surgery , Tooth Socket/pathology , Lasers, Semiconductor/therapeutic use , Osteocalcin , Tooth Extraction/methods , Alveolar Bone Loss/pathology
2.
Ann Anat ; 246: 152024, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36396018

ABSTRACT

PURPOSE: This review aimed to investigate the clinical outcomes of autogenous particulated dentin (APD) used for alveolar ridge preservation (ARP), evaluating volume gain, histologic/histomorphometric data, and associated complications. MATERIAL AND METHODS: The review followed PRISMA guidelines and was registered in the International Prospective Register of Systematic Reviews (PROSPERO). An automated search was made in four databases (Medline/Pubmed, Scopus, Web of Science, and Cochrane Library) supplemented by a manual search for relevant clinical articles published before March 10th, 2022. The review included human studies of at least four patients in which extraction and subsequent ARP were performed in a single surgery. Both comparative studies and studies that assessed ARP with APD exclusively were admitted. The quality of evidence was assessed with the Cochrane bias assessment tool, the Newcastle-Ottawa Quality Assessment Scale, and the Joanna Briggs Institute Critical Appraisal tool. RESULTS: Eleven studies fulfilled the inclusion criteria and were included for descriptive analysis, with a total of 215 patients, and 337 alveoli preserved by APD, spontaneous healing (blood clot), or other bone substitutes, obtaining comparatively less vertical and horizontal resorption when APD was used. CONCLUSIONS: After dental extraction, autogenous dentin was effective in terms of volume maintenance, showing promising results in histologic/histomorphometric analysis, and a low complication rate. Nevertheless, few comparative studies with comparable parameters have been published and so more research providing long-term data is needed to confirm these findings.


Subject(s)
Alveolar Ridge Augmentation , Bone Substitutes , Humans , Alveolar Ridge Augmentation/methods , Bone Transplantation/methods , Minerals , Alveolar Process/surgery , Dentin , Tooth Socket/surgery , Tooth Extraction
3.
Nutrients ; 13(10)2021 Oct 12.
Article in English | MEDLINE | ID: mdl-34684576

ABSTRACT

Numerous studies highlight that astaxanthin (ASTX) ameliorates hyperglycemic condition and hyperglycemia-associated chronic complications. While periodontitis and periodontic tissue degradation are also triggered under chronic hyperglycemia, the roles of ASTX on diabetes-associated periodontal destruction and the related mechanisms therein are not yet fully understood. Here, we explored the impacts of supplemental ASTX on periodontal destruction and systemic complications in type I diabetic mice. To induce diabetes, C57BL/6 mice received a single intraperitoneal injection of streptozotocin (STZ; 150 mg/kg), and the hyperglycemic mice were orally administered with ASTX (12.5 mg/kg) (STZ+ASTX group) or vehicle only (STZ group) daily for 60 days. Supplemental ASTX did not improve hyperglycemic condition, but ameliorated excessive water and feed consumptions and lethality in STZ-induced diabetic mice. Compared with the non-diabetic and STZ+ASTX groups, the STZ group exhibited severe periodontal destruction. Oral gavage with ASTX inhibited osteoclastic formation and the expression of receptor activator of nuclear factor (NF)-κB ligand, 8-OHdG, γ-H2AX, cyclooxygenase 2, and interleukin-1ß in the periodontium of STZ-injected mice. Supplemental ASTX not only increased the levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and osteogenic transcription factors in the periodontium, but also recovered circulating lymphocytes and endogenous antioxidant enzyme activity in the blood of STZ-injected mice. Furthermore, the addition of ASTX blocked advanced glycation end products-induced oxidative stress and growth inhibition in human-derived periodontal ligament cells by upregulating the Nrf2 pathway. Together, our results suggest that ASTX does not directly improve hyperglycemia, but ameliorates hyperglycemia-triggered periodontal destruction and oxidative systemic complications in type I diabetes.


Subject(s)
Antioxidants/metabolism , Diabetes Mellitus, Experimental/complications , NF-E2-Related Factor 2/metabolism , Oxidative Stress , Periodontitis/drug therapy , Periodontitis/etiology , Streptozocin/administration & dosage , Adolescent , Alveolar Process/pathology , Animals , Blood Glucose/metabolism , Catalase/blood , Cell Proliferation , Cytokines/metabolism , DNA Damage , Diabetes Mellitus, Experimental/blood , Dietary Supplements , Feeding Behavior , Glycation End Products, Advanced/metabolism , Humans , Hyperglycemia/complications , Inflammation Mediators/metabolism , Injections , Lymphocytes/immunology , Male , Mice, Inbred C57BL , Osteoclasts/drug effects , Osteoclasts/pathology , Periodontal Ligament/pathology , Periodontitis/blood , Reactive Oxygen Species/metabolism , Superoxide Dismutase/blood , Up-Regulation , Xanthophylls/pharmacology , Xanthophylls/therapeutic use , Young Adult
4.
Sci Rep ; 11(1): 15446, 2021 07 29.
Article in English | MEDLINE | ID: mdl-34326432

ABSTRACT

The incidence of oral cavity squamous cell carcinoma (OSCC) is particularly high in South Asia. According to the National Comprehensive Cancer Network, OSCC can arise in several subsites. We investigated survival rates and the clinical and pathological characteristics of OSCC in different anatomical subsites in the Taiwanese population. We retrospectively analyzed data for 3010 patients with OSCC treated at the Changhua Christian Hospital. Subsequently, we compared clinical and pathological features of OSCC in different subsites. Pathological T4 stage OSCCs occurred in the alveolar ridge and retromolar trigone in 56.4% and 43.7% of cases, respectively. More than 25% of patients with tongue OSCC and 23.4% of those with retromolar OSCC had lymph node metastasis. The prognosis was worst for hard palate OSCC (hazard ratio 1.848; p < 0.001) and alveolar ridge OSCC (hazard ratio 1.220; p = 0.017). Retromolar OSCC recurred most often and tongue OSCC second most often. The risk for cancer-related mortality was highest for hard palate OSCC, followed by alveolar ridge and retromolar OSCC. We found distinct differences in survival among the different subsites of OSCC. Our findings may also help prompt future investigations of OSCC in different subsites in Taiwanese patients.


Subject(s)
Alveolar Process/pathology , Lip Neoplasms/mortality , Mouth Mucosa/pathology , Palatal Neoplasms/mortality , Squamous Cell Carcinoma of Head and Neck/mortality , Tongue Neoplasms/mortality , Adult , Aged , Female , Follow-Up Studies , Humans , Lip Neoplasms/epidemiology , Lip Neoplasms/pathology , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Staging , Palatal Neoplasms/epidemiology , Palatal Neoplasms/pathology , Prognosis , Retrospective Studies , Risk Factors , Squamous Cell Carcinoma of Head and Neck/epidemiology , Squamous Cell Carcinoma of Head and Neck/pathology , Survival Rate , Taiwan/epidemiology , Tongue Neoplasms/epidemiology , Tongue Neoplasms/pathology
5.
Int J Implant Dent ; 7(1): 49, 2021 06 01.
Article in English | MEDLINE | ID: mdl-34059974

ABSTRACT

BACKGROUND: The present study aims to assess the influence of low-level laser therapy (LLLT) on stability in implants placed in healed sites. MATERIAL AND METHODS: The present study followed the SPIRIT statement and is reported according to CONSORT. Patients were randomly allocated to LLLT or control groups. LLLT consisted in the application of 808-nm GaAlA laser applied before the preparation of the implant bed and after suturing (80 seconds; 11J/cm2). Implant stability quotient (ISQ) and the distance between the implant platform to the alveolar bone crest (millimeters) were assessed at implant placement (T0) and the abutment selection phase (4-6 months, Ta). RESULTS: A total of 64 implants were placed in 33 patients. The insertion torque ranged from 10 to 70 N.cm (mean 43.23; SD ±16.82). The T0 ISQ ranged from 18 to 95.5 (mean 61.7; SD ±18.23) and the crestal bone radiographic distance was 2.03 mm (SD±1.27). At Ta, the ISQ ranged from 39 to 90 (mean 64.2; SD±9.84), and the mean crestal bone radiographic loss was 1.70mm (SD±1.65). However, no differences were observed when LLLT and control groups were compared with ISQ difference (Ta-T0; p=0.598) or radiographical peri-implant alterations (p=0.531). CONCLUSION: LLLT did not influence the implant stability in implants placed in healed sites compared to a control group. TRIAL REGISTRATION: ReBEC, RBR-35TNJ7 . Registered May 23, 2018.


Subject(s)
Low-Level Light Therapy , Alveolar Process , Humans , Prostheses and Implants , Radiography , Torque
6.
Sci Rep ; 11(1): 7672, 2021 04 07.
Article in English | MEDLINE | ID: mdl-33828221

ABSTRACT

Zoledronic acid (ZA) is often prescribed for osteoporosis or resorptive metabolic bone disease. This study aims to evaluate the effect of ZA on orthodontic tooth movement (OTM) and root and bone resorption and its repercussion on root, periodontal ligament and alveolar bone tissues. The experimental group consisted of 72 Wistar rats divided in four subgroups: Naive, Saline and Zoledronic Acid groups at the concentration of 0.2 mg/kg [ZA (0.2)] or 1.0 mg/kg [ZA (1.0)]. The animals were subjected to i.v (dorsal penile vein) administrations of ZA or saline solution, on days 0, 7, 14 and 42. Under anesthesia, NiTi springs were installed in the first left maxillary molar with 50gf allowing the OTM, except for the negative control group (N) for mesial movement of the left first maxillary teeth. The animals were sacrificed and maxillae were removed for macroscopic and histopathological analyzes, scanning electron microscopy, computerized microtomography and confocal microscopy. Treatment with ZA decreased the OTM and the number of osteoclasts and loss of alveolar bone when compared to the naive and saline groups. Reduction of radicular resorption, increased necrotic areas and reduced vascularization in the periodontal ligament were observed in the ZA groups. ZA interferes with OTM and presents anti-resorptive effects on bone and dental tissues associated with a decreased vascularization, without osteonecrosis.


Subject(s)
Alveolar Process/drug effects , Bone Density Conservation Agents/adverse effects , Periodontal Ligament/drug effects , Tooth Movement Techniques , Tooth Root/drug effects , Zoledronic Acid/adverse effects , Animals , Bone Density Conservation Agents/administration & dosage , Bone Resorption/prevention & control , Drug Evaluation, Preclinical , Male , Osteoporosis/drug therapy , Rats, Wistar , Zoledronic Acid/administration & dosage
7.
Head Neck ; 43(1): 203-211, 2021 01.
Article in English | MEDLINE | ID: mdl-32969107

ABSTRACT

BACKGROUND: Alveolar ridge squamous cell carcinoma (ARSCC) is poorly represented in randomized trials. METHODS: Adults in the National Cancer Database diagnosed with ARSCC between 2010 and 2014 who should be considered for postoperative radiotherapy (PORT) based on National Comprehensive Cancer Network (NCCN)-defined risk factors were identified. RESULTS: Eight hundred forty-five (58%) of 1457 patients meeting the inclusion criteria received PORT. PORT was associated with improved overall survival (OS) on unadjusted (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.70-0.98, P = .02) and multivariable (HR 0.78, 95% CI 0.64-0.94, P = .002) analyses. PORT was associated with significantly improved 5-year OS for patients with 1 (68% vs 58%, P < .001), 2 (52% vs 31%, P < .001), and ≥3 (38% vs 24%, P < .001) NCCN-defined risk factors. Prognostic variables significantly associated with worse OS on multivariable analysis included advanced age, primary tumor size ≥3 cm, high grade, positive margin(s), stage N2-3, level IV/V nodal metastasis, and extranodal extension. CONCLUSION: PORT for resected ARSCC with adverse pathologic features is associated with significantly improved OS.


Subject(s)
Carcinoma, Squamous Cell , Adult , Alveolar Process , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/surgery , Humans , Neoplasm Staging , Prognosis , Radiotherapy, Adjuvant , Retrospective Studies
8.
Clin Implant Dent Relat Res ; 22(3): 261-269, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32329198

ABSTRACT

BACKGROUND: Low-level laser therapy (LLLT) has been suggested to improve primary stability at the early stages of osseointegration in animal models. However, there is still scarce evidence about its influence on implant stability in humans. PURPOSE: To assess the influence of LLLT on implant stability in implants placed in fresh extraction sockets. MATERIAL AND METHODS: A randomized controlled trial was designed according to the SPIRIT guidelines and is reported following the CONSORT. Patients were randomly allocated according to control or LLLT groups. LLLT consisted in the application of GaAlAs laser (808 nm, avg. power density: 50 mW, circular spot diameter and area: 0.71 cm/0.4cm2 ) applied in six points in contact mode with peri-implant soft tissue (1.23 minutes in each point of application; dose per point 11 J) before bone perforation and after suturing. The total dose resulted in 66 J per application moment. This LLLT protocol was applied only in the dental implant placement session. Implant stability was by ISQ at implant placement (T0 ) and the abutment selection (Ta ). Digital radiographs for T0 and Ta were used to assess the distance between the implant platform and alveolar bone crest, in millimeters. T-test and Shapiro-Wilk test were used to analyze data between groups using the implant as a unit of analysis. RESULTS: Fifty implants were placed in 44 patients. The insertion torque ranged from 15 to 60 N.cm (mean 35.64 ± 13.34). Two implants of the LLLT and one of the control groups were lost to follow-up and one implant of the control group failed to osseointegrate (4.3%). ISQ at T0 ranged from 17 to 79 (mean 59.33 ± 13.05) and from 40 to 89 (mean 66.46 SD ± 11.56) at Ta . No differences were observed when comparing the groups with ISQ difference (P = .433) or radiographical peri-implant alterations (P = .261). CONCLUSIONS: LLLT did not influence implant stability in implants placed in fresh extraction sockets when assessed at healing abutment installation.


Subject(s)
Dental Implants , Low-Level Light Therapy , Alveolar Process , Animals , Dental Implantation, Endosseous , Humans , Osseointegration , Tooth Socket/surgery
9.
Clin Oral Investig ; 24(8): 2591-2601, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31797170

ABSTRACT

OBJECTIVES: The purpose of this study was to investigate the role of hyperbaric oxygen (HBO) in the healing of teeth extraction sockets and in alveolar ridge preservation. This may provide an experimental basis for the widespread application of HBO in oral implantation. METHODS: A total of 32 beagle dogs were included in the study and randomly divided equally between an HBO group treated with hyperbaric oxygen (100% O2, 2.4 atm, 90 min/day, 5 times/week, 6 weeks) and a normobaric oxygen (NBO) group treated with normal air in the same chamber. The lateral incisors of the maxillary and mandible of each dog were extracted, and the right upper and lower incisor extraction sockets (A2C2) were allowed to heal naturally, while left upper and lower incisor sockets (B2D2) received implants of a commercial bone substitute. At 4 and 8 weeks after surgery, clinical observation, cone-beam computerized tomography (CBCT), histomorphology observation, and expression levels of vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2) were analyzed to evaluate new bone formation, mineralization, and reconstruction. RESULTS: After 4 and 8 weeks, bone width and lip contour of the extraction socket in the NBO group were significantly reduced and collapsed in comparison with the HBO group. CBCT showed that the difference in vertical height between the alveolar crest of the labial tongue and palatal side of the extraction sockets was smaller in the HBO than NBO group. There was a significant difference in new bone formation (P < 0.05) and bone mineral density (P < 0.05) between the HBO and NBO groups, and the HBO group showed significantly greater new bone and bone reconstruction based on histology. Furthermore, the expression levels of VEGF and BMP-2 were higher in the HBO group. CONCLUSION: HBO reduced bone resorption and promoted early bone formation, bone mineralization, and reconstruction in the extraction sockets. HBO greatly reduced the healing time of the extraction sockets and promoted alveolar ridge preservation, thus showing promise for the clinic.


Subject(s)
Alveolar Bone Loss , Alveolar Ridge Augmentation , Hyperbaric Oxygenation , Tooth Extraction , Alveolar Process , Animals , Dogs , Oxygen , Tooth Socket , Vascular Endothelial Growth Factor A
10.
Rev. Asoc. Odontol. Argent ; 107(2): 54-62, abr.-jun. 2019. ilus
Article in Spanish | LILACS | ID: biblio-1015871

ABSTRACT

Objetivo: Presentar una técnica quirúrgica de disyunción con bisturí piezoeléctrico y expansión de rebordes delgados en maxilar inferior que permita la colocación de implantes en la posición tridimensional correcta en el mismo acto quirúrgico. Casos clínicos: Se presenta la resolución de dos casos clínicos de pacientes que acudieron a la Cátedra de Odontología Integral Adultos de la Facultad de Odontología de la Universidad de Buenos Aires. Ambos requerían la colocación de implantes en sectores posteroinferiores. Las imágenes tomográficas mostraban adecuada altura del reborde alveolar pero deficiente espesor para la colocación de implantes en la posición tridimensional correcta. Se decidió realizar una técnica de disyunción horizontal del reborde alveolar con bisturí piezoeléctrico, expansión del reborde y colocación de implantes e injerto óseo particulado de forma simultánea. Luego de 3 meses, se efectuó la segunda cirugía para iniciar la rehabilitación protésica. Conclusión: La técnica de disyunción horizontal del reborde alveolar mediante el uso del bisturí piezoeléctrico permitió ubicar al implante en la posición tridimensional correcta dentro del tejido óseo nativo sin la necesidad de realizar regeneraciones complejas en rebordes alveolares delgados (AU)


Aim: Present the horizontal split crest technique with a piezoelectric scalpel and the immediate implant placement in the correct tridimensional position, in thin mandibular alveolar ridges. Cases report: The surgical resolutions of 2 clinical cases of patients who attended the Adult Integral Dentistry Chair of the Faculty of Dentistry of the UBA, are presented. Both patients required implant placement in posterior madibular residual ridge. The tomographic images showed adequate height of the alveolar ridge but poor thickness for implants placement in a correct three-dimensional position. It was decided to perform a horizontal split crest technique of the alveolar ridge with piezoelectric scalpel, ridge expansion, and immediate implant placement with xenograft. After 3 months, the second surgery was performed to start with the prosthetic rehabilitation. Conclusion: The horizontal split crest technique using a piezoelectric scalpel, allowed immediate implant placement in the correct tridimensional position within native bone tissue, avoiding a guided bone regeneration technique, in these cases with thin alveolar ridges (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Palatal Expansion Technique , Dental Implantation, Endosseous , Piezosurgery/methods , Argentina , Schools, Dental , Osseointegration , Bone Transplantation/methods , Alveolar Process/surgery , Mouth Rehabilitation
11.
Clin Oral Investig ; 23(11): 4083-4097, 2019 Nov.
Article in English | MEDLINE | ID: mdl-30771000

ABSTRACT

OBJECTIVES: Evaluate the bone remodeling during orthodontic movement with corticotomy when submitted to low-intensity electrical stimulation application (microcurrent-MC) and low-level laser therapy (LLLT). MATERIAL AND METHODS: One hundred and fifty Wistar rats were divided into the following 5 groups: (C) submitted to tooth movement; (Cort) tooth movement/corticotomy; (Cort-L) tooth movement/corticotomy/laser AsGaAl 808 nm (4.96J/50s); (Cort-Mc) tooth movement/corticotomy/microcurrent (10 µA/5 min); (Cort-L-Mc) tooth movement/corticotomy and laser/microcurrent alternated. Inflammation, angiogenesis, and osteogenesis were evaluated in the periodontal ligament (PDL) and alveolar bone on the 7th, 14th, and 21st days of orthodontic movement. RESULTS: The quantification of inflammatory infiltrate, angiogenesis and expression of TGF-ß1, VEGF, and collagen type I were favorably modulated by the application of therapies such as low-level laser therapy (LLLT), MC, or both combined. However, electrical stimulation increased fibroblasts, osteoclasts and RANK numbers, birefringent collagen fiber organization, and BMP-7 and IL-6 expression. CONCLUSIONS: Low-level laser therapy (LLLT) and MC application both improved the process of bone remodeling during orthodontic treatment with corticotomy. Still, electrical current therapy promoted a more effective tooth displacement but presented expected root resorption similar to all experimental treatments. CLINICAL RELEVANCE: It is important to know the effects of minimally invasive therapies on cellular and molecular elements involved in the bone remodeling of orthodontic treatment associated with corticotomy surgery, in order to reduce the adverse effects in the use of this technique and to establish a safer clinical routine.


Subject(s)
Bone Remodeling , Laser Therapy , Tooth Movement Techniques , Alveolar Process , Animals , Male , Rats , Rats, Wistar , Root Resorption
12.
Int J Periodontics Restorative Dent ; 39(3): 381­389, 2019.
Article in English | MEDLINE | ID: mdl-29677227

ABSTRACT

This study evaluated the impact of soft tissue grafts to reduce marginal peri-implant recession (MPR) after 1 year of follow-up. A total of 24 patients with one single failing maxillary incisor presenting facial bone dehiscence and receiving an immediate implant, bone graft, and provisional were randomly divided into three groups (n = 8 in each group): control (CTL), collagen matrix (CM), and connective tissue graft (CTG). Clinical, photographic, and tomographic analyses were performed to evaluate tissue alterations. The use of a CTG avoided MPR (P < .05) and provided better contour of the alveolar ridge (P < .01) and greater thickness (P < .05) of the soft tissue at the implant facial aspect.


Subject(s)
Dental Implants, Single-Tooth , Therapy, Soft Tissue , Alveolar Process , Connective Tissue , Humans , Incisor , Maxilla , Treatment Outcome
13.
Implant Dent ; 27(6): 653-659, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30334847

ABSTRACT

PURPOSE: The impact of hyperbaric oxygen (HBO) on the healing of bone tissues around implants was studied using an animal model. METHODS: A total of 32 beagle dogs were selected and randomly divided into the HBO group and the blank group. The dogs in the HBO group were subjected to 90 minutes of HBO therapy. X-ray, cone-beam computerized tomography imaging, implant stability quotient (ISQ) values, histological observation, quantitative analysis of bone histomorphometry, and hematoxylin-eosin (HE) and Masson staining were evaluated. RESULTS: In this study, at 4 weeks after the surgery, the mean ISQ value in the HBO group was higher than that in the blank group, and the difference had statistical significance (P < 0.05). At week 4 and 8, the mean values of bone ingrowth fraction (BIC%) and the percentage of bone area (BA%) in the HBO group were both higher than those of the blank group. Decalcified paraffin sections were stained with HE and Masson staining showed that the bone tissue around the implant in the HBO group has more osteoblasts than control group, and many irregular marrow cavities and Haversian bone plates were observed in the new bone tissue. CONCLUSION: This study showed that after implantation, early osteogenesis was better in the HBO group than in the blank group. On one hand, the healing time of the bone tissue around the implants was reduced.


Subject(s)
Dental Implantation, Endosseous , Hyperbaric Oxygenation , Wound Healing , Alveolar Process/diagnostic imaging , Alveolar Process/pathology , Animals , Bone Development , Cone-Beam Computed Tomography , Dental Implantation, Endosseous/methods , Dogs , Hyperbaric Oxygenation/methods , Radiography, Dental
14.
Dent Med Probl ; 55(2): 125-131, 2018.
Article in English | MEDLINE | ID: mdl-30152614

ABSTRACT

BACKGROUND: Obesity is a worldwide medical problem in which excess body fat is accumulated in the body. The use of weight loss supplements such as green coffee bean extract and Agiolax has become a common trend among people who want to lose weight in a fast and non-tiring way. As a result of their effect on fluid excretion, both of these products may be expected to have a damaging effect on the alveolar bone. OBJECTIVES: The aim of the present study was to evaluate the histopathalogical effect of green coffee bean extract as compared to Agiolax on the alveolar bone of albino rats. MATERIAL AND METHODS: Twenty-seven adult male albino rats were randomly assigned to 3 groups. Nine received distilled water daily for 2 months by oral gavage (the control group); the other 2 groups received 1 mg/100 g body weight green coffee bean extract or Agiolax 8 mg/100 g body weight daily for 2 months by oral gavage (the GC and Ag groups, respectively). The alveolar bones were dissected and examined histologically, histomorphometrically and by western blotting. RESULTS: The bone area percentage and the calcium level in serum were significantly decreased in the GC and Ag groups, while the calcium level in urine was significantly increased in both the experimental groups as compared to the control group. On the other hand, RANKL expression was significantly increased only in the GC group, and the tissue calcium (Ca) level was significantly decreased only in the GC group as compared to the control group. CONCLUSIONS: Long-term oral administration of green coffee bean extract and Agiolax might lead to alveolar bone loss. A greater deleterious effect was caused by green coffee bean extract, as it caused more RANKL expression, significantly reduced Ca level in the tissue and consequently decreased the bone area percentage.


Subject(s)
Alveolar Process/drug effects , Anti-Obesity Agents/pharmacology , Coffee , Plant Extracts/pharmacology , Senna Extract/pharmacology , Alveolar Process/metabolism , Alveolar Process/pathology , Animals , Calcium/metabolism , Drug Combinations , Models, Animal , Plantago , RANK Ligand/metabolism , Rats
15.
Dent Med Probl ; 55(2): 197-206, 2018.
Article in English | MEDLINE | ID: mdl-30152625

ABSTRACT

Technological progress and the introduction of modern therapeutic methods are constantly changing contemporary orthodontics. More and more orthodontic patients are working adults, who expect satisfactory therapeutic effects as soon as possible, increasing the importance of methods accelerating tooth movement. The aim of this study was to review the current literature regarding methods of accelerating tooth movement and reducing the duration of the active phase of therapy. The literature was collected from the PubMed and EBSCO databases using "accelerated orthodontic tooth movement" as the search key words. The methods described were categorized as conservative and surgical. The pharmacological agents used in conservative treatment, such as growth hormone, parathyroid hormone, thyroxine, and vitamin D, are especially worth mentioning. They stimulate osteoclasts to increase resorption through a variety of mechanisms. Effective methods also include physical stimuli, e.g., vibrations or photobiomodulation. Most studies describing the effects of pharmacological agents were based on animal subjects and they may therefore lack clinical relevancy. Corticotomy and its modifications based on the regional acceleratory phenomenon (RAP) might prove to be a useful augmentation of orthodontic treatment, especially in adults, including patients with periodontal disease.


Subject(s)
Tooth Mobility , Tooth Movement Techniques/methods , Adrenergic beta-2 Receptor Antagonists/therapeutic use , Alveolar Process/surgery , Cortical Bone/surgery , Electromagnetic Fields , Growth Hormone/therapeutic use , Humans , Low-Level Light Therapy , Magnetic Field Therapy , Parathyroid Hormone/therapeutic use , Piezosurgery , Thyroxine/therapeutic use , Vibration/therapeutic use , Vitamin D/therapeutic use , Vitamins/therapeutic use
16.
Implant Dent ; 27(5): 547-554, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30059390

ABSTRACT

PURPOSE: The aim of this study was to evaluate the bone formed after maxillary sinus floor augmentation (MSFA) by bone autografting combined with hydroxyapatite (HA) that had been either treated with low-level laser therapy (LLLT) or not. MATERIALS AND METHODS: Twelve biopsies were obtained from patients 6 months after MSFA using a combination of 50% of autogenous bone (AB) and 50% of HA (AB/HA group, n = 6) followed by LLLT (AB/HA-LLLT group, n = 6). The laser used in this study was gallium-aluminium-arsenide laser with a wavelength of 830 nm (40 mW; 5.32 J/point; 0.57 W/cm). Samples obtained were subjected to histological, histometric, and immunohistochemical analysis for detection of tartrate-resistant acid phosphatase and runt-related transcription factor 2. The data were submitted to statistical analysis (Shapiro-Wilk and Student t tests; α = 5%). RESULTS: Statistical analysis revealed no significant difference in vital bone presence and immunohistochemical analysis between the groups. There was no reduction in bone marrow or fibrous tissue in the AB/HA group and AB/HA-LLLT group. There was a decrease in the amount of remaining biomaterial between the groups (P = 0.0081). CONCLUSION: LLLT did not increase the formation of new bone; instead, it accelerated the bone remodeling process.


Subject(s)
Bone Transplantation/methods , Durapatite/therapeutic use , Low-Level Light Therapy , Osteogenesis , Sinus Floor Augmentation/methods , Adult , Alveolar Process/pathology , Humans , Low-Level Light Therapy/adverse effects , Low-Level Light Therapy/methods , Middle Aged , Young Adult
17.
J Craniomaxillofac Surg ; 46(7): 1147-1152, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29805068

ABSTRACT

PURPOSE: The aim of this study was to evaluate the effects of helium-neon and gallium-aluminum-arsenide lasers with various doses on bone healing following tooth extraction. MATERIALS AND METHODS: Maxillary right incisor teeth of 30 female albino Wistar rats were extracted. Five groups were established: four groups treated with helium-neon or gallium-aluminum-arsenide lasers and a control group. Both laser groups' rats received energy doses of 6 J/cm2 and 10 J/cm2 for 7 days. At the end of 30 days, all subjects were sacrificed for histological and morphological evaluations. RESULTS: Laser groups showed faster bone healing and gallium-aluminum-arsenide lasers increased vascular immunoreactivity. The most widespread organized bone formation in the extraction socket was observed in the gallium-aluminum-arsenide laser group with the energy dose of 10 J/cm2 (p < 0.05). CONCLUSION: This study demonstrated that low-level laser therapies were effective on alveolar bone healing and that an energy dose of 10 J/cm2 did not have an inhibition effect on bone regeneration.


Subject(s)
Alveolar Process/radiation effects , Lasers, Gas/therapeutic use , Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy , Tooth Extraction , Wound Healing/radiation effects , Alveolar Process/pathology , Alveolar Process/physiology , Animals , Female , Osteogenesis/radiation effects , Radiotherapy Dosage , Rats, Wistar , Wound Healing/physiology
18.
J Periodontal Res ; 53(3): 478-486, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29446089

ABSTRACT

OBJECTIVE: Grape seed proanthocyanidine extract (GSPE) is a strong antioxidant derived from the grape seeds (Vitis vinifera, Terral J.F.) and has a polyphenolic structure with a wide range of biological activity. The aim of the present study was to evaluate the effects of GSPE on alveolar bone loss and histopathological changes in rats with diabetes mellitus and ligature-induced periodontitis. MATERIAL AND METHODS: Forty rats were divided into 6 study groups. Control (C, 6 rats) group, periodontitis (P, 6 rats) group, diabetes (D, 6 rats) group, diabetes and periodontitis (D+P, 6 rats) group, diabetes, periodontitis and 100 mg/kg/day GSPE (GSPE-100, 8 rats), and diabetes, periodontitis and 200 mg/kg/day GSPE (GSPE-200, 8 rats) group. Diabetes mellitus was induced by intraperitoneal injection of a single dose of streptozotocin (60 mg/kg). Periodontitis was induced via ligation method. Silk ligatures were placed at the mandibular right first molars. GSPE was administered by oral gavage. After 30 days, all rats were killed. Alveolar bone loss was measured morphometrically via a stereomicroscope. For histopathological analyses, Alizarin red staining, and matrix metalloproteinase (MMP)-8, vascular endothelial growth factor and hypoxia inducible factor (HIF)-1α immunohistochemistry were performed. Tartrate-resistant acid phosphatase-positive osteoclast cells and relative total inflammatory cells were also determined. RESULTS: The highest alveolar bone loss was observed in the D+P group (P < .05). GSP-200 group decreased alveolar bone loss (P < .05). The D+P group had the highest osteoclast counts, but the difference was not significant compared to the P, GSPE-100 and GSPE-200 groups (P > .05). The inflammation in the D+P group was also higher than the other groups (P < .05). The osteoblast numbers increased in the GSPE-100 and GSPE-200 groups compared to the P and D+P groups (P < .05). MMP-8 and HIF-1α levels were highest in the D+P group and GSPE significantly decreased these levels (P < .05). CONCLUSION: Within the limits of this animal study, it can be suggested that GSPE administration may decrease periodontal inflammation and alveolar bone loss via decreasing MMP-8 and HIF-1α levels and increase osteoblastic activity in diabetic rats with experimental periodontitis.


Subject(s)
Alveolar Bone Loss/drug therapy , Alveolar Bone Loss/pathology , Diabetes Mellitus, Experimental/complications , Grape Seed Extract/pharmacology , Grape Seed Extract/therapeutic use , Periodontitis/drug therapy , Periodontitis/pathology , Proanthocyanidins/pharmacology , Proanthocyanidins/therapeutic use , Alveolar Bone Loss/classification , Alveolar Process/pathology , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Blood Glucose/analysis , Body Weight , Disease Models, Animal , Grape Seed Extract/administration & dosage , Hypoxia-Inducible Factor 1/analysis , Immunohistochemistry , Inflammation/drug therapy , Inflammation/pathology , Injections, Intraperitoneal , Ligation/adverse effects , Male , Matrix Metalloproteinase 8/analysis , Osteoblasts/drug effects , Osteoblasts/pathology , Osteoclasts/drug effects , Osteoclasts/pathology , Proanthocyanidins/administration & dosage , Rats , Rats, Wistar , Streptozocin/administration & dosage , Streptozocin/pharmacology , Tartrate-Resistant Acid Phosphatase/analysis , Vascular Endothelial Growth Factor A/analysis
19.
J Oral Maxillofac Surg ; 76(2): 287.e1-287.e10, 2018 02.
Article in English | MEDLINE | ID: mdl-29125929

ABSTRACT

PURPOSE: This study investigated the effect of a gallium-aluminum-arsenide (GaAlAs) diode laser used in low-level laser therapy (LLLT) with the application of Mecsina Hemostopper on mandibular alveolar bone healing. MATERIALS AND METHODS: Standard semispherical bone defects were created in left mandibular diastema sites of 32 female Long-Evans rats. Experimental animals were allocated to 1 of 4 groups: control group (no treatment), laser group (GaAlAs LLLT), Mecsina group, and laser-Mecsina combination group. Liquid Mecsina 0.01 mL was applied to the bone defects. Laser treatment was performed for 7 days after surgery at an energy dose of 10 J/cm2. All animals were sacrificed to observe hard tissue healing histologically, immunohistochemically, and radiologically at 30 days after surgery. RESULTS: Histologic assessment showed significantly more calcified tissue areas and significantly more osteoblast cells in the laser and laser-Mecsina groups than in the other groups (P < .01). Qualitative morphologic assessment showed that more bone tissue was present in the laser-Mecsina group than in the other groups. CONCLUSION: This study showed that LLLT, Mecsina application, and combined treatments were effective in healing alveolar bone among all tested treatment modalities.


Subject(s)
Alveolar Process/drug effects , Alveolar Process/radiation effects , Hemostatics/pharmacology , Low-Level Light Therapy/instrumentation , Wound Healing/drug effects , Wound Healing/radiation effects , Animals , Female , Lasers, Semiconductor , Mandible/surgery , Rats
20.
Nano Lett ; 17(10): 6210-6216, 2017 10 11.
Article in English | MEDLINE | ID: mdl-28892393

ABSTRACT

Osteocytes are contained within spaces called lacunae and play a central role in bone remodelling. Administered frequently to prevent osteoporotic fractures, antiresorptive agents such as bisphosphonates suppress osteocyte apoptosis and may be localized within osteocyte lacunae. Bisphosphonates also reduce osteoclast viability and thereby hinder the repair of damaged tissue. Osteocyte lacunae contribute to toughening mechanisms. Following osteocyte apoptosis, the lacunar space undergoes mineralization, termed "micropetrosis". Hypermineralized lacunae are believed to increase bone fragility. Using nanoanalytical electron microscopy with complementary spectroscopic and crystallographic experiments, postapoptotic mineralization of osteocyte lacunae in bisphosphonate-exposed human bone was investigated. We report an unprecedented presence of ∼80 nm to ∼3 µm wide, distinctly faceted, magnesium whitlockite [Ca18Mg2(HPO4)2(PO4)12] crystals and consequently altered local nanomechanical properties. These findings have broad implications on the role of therapeutic agents in driving biomineralization and shed new insights into a possible relationship between bisphosphonate exposure, availability of intracellular magnesium, and pathological calcification inside lacunae.


Subject(s)
Alveolar Process/drug effects , Bone Density Conservation Agents/pharmacology , Calcium Phosphates/chemistry , Diphosphonates/pharmacology , Magnesium/chemistry , Osteocytes/drug effects , Alveolar Process/chemistry , Alveolar Process/cytology , Alveolar Process/pathology , Apoptosis/drug effects , Bone Density Conservation Agents/therapeutic use , Crystallization , Diphosphonates/therapeutic use , Female , Humans , Osteocytes/chemistry , Osteocytes/cytology , Osteocytes/pathology , Osteoporotic Fractures/drug therapy , Osteoporotic Fractures/pathology
SELECTION OF CITATIONS
SEARCH DETAIL